Difference between revisions of "WSI24-212-Case-3"

From MGH Learn Pathology
Line 74: Line 74:
 
|frames=6
 
|frames=6
 
|status=completed
 
|status=completed
 +
|reasonCode=Insulin
 
|view=hide
 
|view=hide
 
|identifier=86bf9e19-93de-4ec7-96da-868b4436f887
 
|identifier=86bf9e19-93de-4ec7-96da-868b4436f887
Line 82: Line 83:
 
|frames=7
 
|frames=7
 
|status=completed
 
|status=completed
 +
|reasonCode=Glucagon
 
|view=hide
 
|view=hide
 
|identifier=5bd64250-6611-4721-bad0-73ec3a32b7ea
 
|identifier=5bd64250-6611-4721-bad0-73ec3a32b7ea
Line 90: Line 92:
 
|frames=8
 
|frames=8
 
|status=completed
 
|status=completed
 +
|reasonCode=Ki67
 
|view=hide
 
|view=hide
 
|identifier=9b5331e8-c244-4138-bfdf-0d07dbc068d0
 
|identifier=9b5331e8-c244-4138-bfdf-0d07dbc068d0
Line 98: Line 101:
 
|frames=9
 
|frames=9
 
|status=completed
 
|status=completed
 +
|reasonCode=Other
 
|view=hide
 
|view=hide
 
|identifier=49e4715d-1c36-49ae-aed1-f9fa53d8526b
 
|identifier=49e4715d-1c36-49ae-aed1-f9fa53d8526b
Line 106: Line 110:
 
|frames=10
 
|frames=10
 
|status=completed
 
|status=completed
 +
|reasonCode=Insulin
 
|view=hide
 
|view=hide
 
|identifier=af7a0133-6a8a-421f-9d21-ff1c6e11bb79
 
|identifier=af7a0133-6a8a-421f-9d21-ff1c6e11bb79
Line 114: Line 119:
 
|frames=11
 
|frames=11
 
|status=completed
 
|status=completed
 +
|reasonCode=Ki67
 
|view=hide
 
|view=hide
 
|identifier=640cf67f-afe3-4f77-836b-c3f12066bc41
 
|identifier=640cf67f-afe3-4f77-836b-c3f12066bc41
Line 122: Line 128:
 
|frames=12
 
|frames=12
 
|status=completed
 
|status=completed
 +
|reasonCode=Other
 
|view=hide
 
|view=hide
 
|identifier=d90d4f9c-d205-484a-93db-b82c8862574a
 
|identifier=d90d4f9c-d205-484a-93db-b82c8862574a
Line 130: Line 137:
 
|frames=13
 
|frames=13
 
|status=completed
 
|status=completed
 +
|reasonCode=CDX2
 
|view=hide
 
|view=hide
 
|identifier=7821fa5f-a463-4f63-bb17-011be5fb011c
 
|identifier=7821fa5f-a463-4f63-bb17-011be5fb011c

Revision as of 14:43, October 3, 2024

WSI24-212-Case-3
57 year old M with a history of MEN1 syndrome.
PANCREATIC WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR/INSULINOMA (1.3 cm; WHO Grade 1 of 3).

DUODENAL WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR/GASTRINOMA (0.9 cm; WHO Grade 1 of 3).

Multiple separate pancreatic neuroendocrine microadenomas (0.1-0.2 cm)
October 4, 2024 12:00:00 PM